视觉中国图 长江商报消息●长江商报记者 黄聪 药明康德（603259.SH、02359.HK）正持续减持药明合联套现。 近日，药明康德发布的公告显示，公司通过大宗交易继续出售所持有的药明合联3030万股股票，约占药 明合联当前总股本的2.47%，成交金额约23.46亿港元。 长江商报记者统计显示，近一年来，药明康德累计减持药明合联股份套现69.5亿港元，按照当前汇率计算 合计63.72亿元人民币。 值得关注的是，2023年和2024年以及2025年上半年，药明康德研发费用连续下滑，两年半合计达31.94亿 元，占同期1003.81亿元营业收入比例仅为3.18%。 而且，近两年半来，药明康德员工人数减少了6529人，降幅达14.72%。 与此形成鲜明对比的是，2022年至2024年，药明康德董事长、执行董事、总裁（首席执行官）李革薪酬 分别为4196.9万元、4196.86万元和4180万元，三年拿走1.26亿元。 近一年四次减持药明合联 近日，药明康德发布的公告显示，公司通过大宗交易继续出售所持有的药明合联3030万股股票，约占药 明合联当前总股本的2.47%，成交金额约23.46亿港元（不包含手续费等交易费 ...

Core Viewpoint - Jin Di Co., Ltd. plans to acquire the controlling stake in Guangzhou Uni Precision Co., Ltd., a subsidiary of Japan's Uni Stamping Co., Ltd., to enhance its market presence and customer base in the precision stamping business in South China [1][4]. Group 1: Acquisition Details - The acquisition framework agreement has been signed, but specific details regarding the acquisition method, ratio, and payment are yet to be determined [1]. - The valuation of Uni Precision has not been established, and the transfer price will be based on the assessment value [1]. - The acquisition scale is expected to reach several hundred million yuan, indicating a significant investment [1]. Group 2: Strategic Rationale - Jin Di Co., Ltd. aims to leverage Uni Precision's customer resources to expand its market share in the precision stamping sector [4]. - The geographical advantage of Uni Precision in Guangdong will help Jin Di fill its market gap in South China, improving asset operation efficiency and market response speed [4][5]. - The acquisition is expected to create strategic synergies, enhancing Jin Di's core competitiveness through the integration of Uni Precision's established stamping technology and customer relationships [5]. Group 3: Financial Performance and Risks - Uni Precision's recent performance trends are not optimistic, primarily due to its deep ties with Nissan, which has seen declining sales in China [6][8]. - Nissan's sales in China have halved from their peak in 2018, impacting Uni Precision's business [8]. - Jin Di Co., Ltd. acknowledges potential integration risks post-acquisition, including cultural and operational alignment challenges [8]. Group 4: Company Background and Recent Developments - Jin Di Co., Ltd. specializes in precision stamping for automotive parts, including bearing retainers and precision components [4]. - The company has been actively investing in various projects, including a 5.3 billion yuan investment in new energy equipment manufacturing [11]. - Jin Di's stock performance has been underwhelming since its IPO, with a recent market capitalization of 2.8 billion yuan and a stock price increase of only about 20% since its issuance [9].

Core Viewpoint - The controlling shareholder and actual controller of Mars Man (300894.SZ) plan to reduce their shareholding through a pre-disclosure announcement, indicating a potential shift in ownership dynamics and liquidity in the market [1][2]. Shareholding Reduction Plan - The controlling shareholder, Hai Ning Da You Investment Partnership (Limited Partnership), and its action partner, Hai Ning Da Hong Investment Partnership (Limited Partnership), plan to reduce their holdings by up to 12,000,000 shares, which is approximately 2.94% of the total share capital [1]. - The reduction will occur over a three-month period from October 14, 2025, to January 13, 2026, through centralized bidding and block trading [1]. Financial Performance - As of June 19, 2025, the reduction plan was completed, with Hai Ning Da You and Hai Ning Da Hong having sold a total of 6,825,900 shares, representing a reduction of 1.67% [2][3]. - The average cash generated from the reduction was approximately 92.52 million yuan [3]. Company Financials - Mars Man's revenue for the reporting period was approximately 374.44 million yuan, a decrease of 46.30% compared to the previous year [6]. - The net profit attributable to shareholders was a loss of approximately 123.53 million yuan, a decline of 400.99% year-on-year [6]. - The company reported a significant drop in cash flow from operating activities, with a net cash flow of -140.52 million yuan, a decrease of 134.29% [6]. Historical Context - Mars Man was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 31, 2020, with an initial issuance of 40.5 million shares at a price of 14.07 yuan per share [3]. - The total funds raised during the IPO amounted to approximately 569.84 million yuan, which was lower than the planned amount by 39.11 million yuan [3].